"Comparable Efficacy of SARS-CoV-2 mRNA Vaccines (BNT162b2 and mRNA-1273) in Fingolimod-Treated Patients with Multiple Sclerosis"

Hammer, H; Kamm, CP; Salmen, A; Hoepner, R (2023). "Comparable Efficacy of SARS-CoV-2 mRNA Vaccines (BNT162b2 and mRNA-1273) in Fingolimod-Treated Patients with Multiple Sclerosis". Biomedical journal of scientific & technical research, 50(1) Biomedical Research Network+ 10.26717/BJSTR.2023.50.007885

[img]
Preview
Text
Hammer__2023__Comparable_Efficacy_of_SARS-CoV-2_mRNA_Vaccines_in_Fingolimod-Treated_Patients_with_MS.pdf - Published Version
Available under License Creative Commons: Attribution-Share Alike (CC-BY-SA).

Download (339kB) | Preview

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Neurology

UniBE Contributor:

Hammer, Helly Noemi, Kamm, Christian Philipp, Salmen, Anke, Hoepner, Robert

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2574-1241

Publisher:

Biomedical Research Network+

Language:

English

Submitter:

Chantal Kottler

Date Deposited:

20 Dec 2023 07:17

Last Modified:

20 Dec 2023 07:19

Publisher DOI:

10.26717/BJSTR.2023.50.007885

BORIS DOI:

10.48350/190359

URI:

https://boris.unibe.ch/id/eprint/190359

Actions (login required)

Edit item Edit item
Provide Feedback